Takeda Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 138

  • Portfolio
  • 54

  • Exits
  • 49

Exits

Takeda Ventures General Information

Description

Founded in 2001, Takeda Ventures is a corporate venture capital arm of Takeda Pharmaceutical Company Limited based in San Diego, California. The firm prefers to invest in seed-stage, early-stage and later-stage companies. It seeks to invest in healthcare, life sciences, oncology sectors in the United States, Western Europe and Canada.

Contact Information

Website
www.takedaventures.com
Formerly Known As
Takeda Research Investment
Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Primary Office
  • 9625 Towne Centre Drive
  • San Diego, CA 92121
  • United States
+1 (619) 000-0000

Takeda Ventures Investments (138)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Harness Therapeutics 28-Nov-2023 Seed Round 000.00 Biotechnology Product In Beta Test 00000 000000 00
Larkspur Biosciences 23-May-2023 00000 00000 000.00 Drug Delivery Startup 00000 0000
Ensoma 16-May-2023 00000 00000 00000 Drug Discovery Clinical Trials - General
OncoResponse 12-May-2023 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2
Cerevance 08-Feb-2023 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2
Enzyre 02-Nov-2022 00000 00000 000.00 Diagnostic Equipment Generating Revenue
hC Bioscience 01-Nov-2022 00000 00000 0000 Biotechnology Startup 00000 0000
Zelluna Immunotherapy 25-Aug-2022 00000 00000 Drug Discovery Generating Revenue 00000 000000 00
Abintus Bio 15-Aug-2022 Early Stage VC 000.00 Drug Discovery Clinical Trials - General 0000000 000000 00.0
Code Bio 25-May-2022 Early Stage VC 0000 Biotechnology Generating Revenue 000000 00000 00
You’re viewing 10 of 138 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Takeda Ventures Exits (49)

Company Name Exit Date Exit Type Exit Size
Turnstone Biologics 24-Jul-2023 IPO 0000
StrideBio 05-Apr-2023 000000000000000000 000
Noile-Immune Biotech 29-Mar-2023 000
Ambys Medicines 23-Feb-2023 000000000000000000
Goldfinch Bio 27-Jan-2023 000 00 00000000
ProteKt Therapeutics 26-Jan-2023 000000000000000000
Redpin Therapeutics 16-Nov-2022 000000000000000000
Coho Therapeutics 26-Sep-2022 000 00 00000000
Arcellx 04-Feb-2022 IPO 00000
VHsquared 25-Jan-2022 Bankruptcy: Liquidation
You’re viewing 10 of 49 exits. Get the full list »

Takeda Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Takeda Ventures Team (19)

Name Title Deals Funds Boards Office
Sacha Mann Senior Investment Director & Partner 0 0 Cambridge, MA
Miles Gerson JD Executive Investment Director & Partner 0 0 Cambridge, MA
Jiaping Gu Ph.D Partner 0 Cambridge, MA
Jim Silva Associate Director & Controller Cambridge, MA
Michael Martin Ph.D Global Head 00 0 San Diego, CA
You’re viewing 5 of 19 team members. Get the full list »